助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   randomized comparative study 在 感染性疾病及传染病 分类中 的翻译结果: 查询用时:0.088秒
图标索引 在分类学科中查询
所有学科
感染性疾病及传染病
药学
外科学
生物学
心血管系统疾病
呼吸系统疾病
肿瘤学
预防医学与卫生学
妇产科学
更多类别查询

图标索引 历史查询
 

randomized comparative study
相关语句
  随机对照
    Two doses of recombinant interferon alpha 2 a in treating chronic hepatitis C: a randomized comparative study
    两种剂量重组干扰素-α2a治疗慢性丙型肝炎随机对照研究
短句来源
    A randomized comparative study of gatifloxacin and ciprofloxacin in the treatment of bacterial infections
    加替沙星与环丙沙星随机对照治疗细菌性感染
短句来源
    Methods A randomized comparative study was conducted to compare the efficacy of meropenem and imipenern in the treatment of 158 cases of moderate to severe infection in ICU.
    方法采用随机对照、平行试验设计,对重症监护病房(ICU)158例中、重度细菌感染患者给予美罗培南治疗并观察临床疗效。
短句来源
  “randomized comparative study”译为未确定词的双语例句
    A randomized comparative study of gatifloxacin and levofloxacin injection in the treatment of bacterial infections
    甲磺酸加替沙星葡萄糖注射液与左氧氟沙星注射液治疗细菌性感染临床疗效观察
短句来源
    Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin
    用Rifabutin治疗近期诊断的肺结核:该药对利福平的多国随机比较性研究
短句来源
    A randomized comparative study of naphtoquine,mefloquine and artsunate in the treatment of falciparum malaria
    磷酸萘酚喹与甲氟喹和青蒿琥酯治疗恶性疟疗效的随机比较
短句来源
    A randomized comparative study on the effect of gatifloxacin andciprofloxacin in the treatment of acute bacterial infections
    甲磺酸加替沙星片治疗急性细菌性感染多中心临床研究
短句来源
查询“randomized comparative study”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  randomized comparative study
The subjects were 65 patients who were enrolled in a multicenter randomized comparative study between April 1997 and March 2001.
      
A randomized comparative study of the TCu380A and Cu-Safe 300 IUDs
      
A randomized comparative study was made in New Zealand of 3 models of copper IUDs, the Nova-T, MLCu375 and MLAgCu250, with interval acceptors.
      
A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375, MLAgCu250): 1-, 2- and 3-year results
      
A randomized comparative study of levonorgestrel-releasing intrauterine device (LNG-IUD) and NorplantR-2 implants was carried out in 200 women for 36 months.
      
更多          


Objective: To evaluate the efficacy and safety of injectable gatifloxacin. Methods; In this multicenter, single-blind, randomized comparative study, patients with infection of lower respiratory tract and urinary tract were allocated randomly to gatifloxacin group or levofloxacin group. In each group patients were given gatifloxacin or levofloxacin intrevenously for 3-5 d followed by oral formulation. Results: (1)The clinical effective rates (gatifloxacin vs. levofloxacin) were 92.4%(110/119) vs. 91.2%(114/...

Objective: To evaluate the efficacy and safety of injectable gatifloxacin. Methods; In this multicenter, single-blind, randomized comparative study, patients with infection of lower respiratory tract and urinary tract were allocated randomly to gatifloxacin group or levofloxacin group. In each group patients were given gatifloxacin or levofloxacin intrevenously for 3-5 d followed by oral formulation. Results: (1)The clinical effective rates (gatifloxacin vs. levofloxacin) were 92.4%(110/119) vs. 91.2%(114/ 125), being 94.296(65/69) vs. 90.296(65/72) for lower respiratory tract infections and 90.0% (45/50) vs. 92.5%(42/72) for urinary tract infections, respectively, there was no statistically significant difference between the two groups; (2)The total bacterial eradication rates were 94.0% (78/83) vs. 88.0% (81/92), being 89.2% (33/37) vs. 92.9% (39/42) for urinary tract infections, there was no statistically significant difference between the two groups; however, the bacterial eradication rate of gatifloxacin (97.8% , 45/46) was higher than that of levofloxacin (84. 3% , 43/51) in lower respiratory tract infections, the difference was statistically significant. (3)Drug-related adverse effects were 29.9% (38/127) in gatifloxacin group, higher than that in levofloxacin group 10.1% (13/129). This is due to more patients with phlebitis and gastrointestinal symptoms in gatifloxacin group than those in levofloxacin group. These drug-related events could be alleviated by slowing down the speed of infusion; the adverse effects of both groups were mild and tolerable, no discontinuation of treatment due to adverse reaction. Drug-related abnormal laboratory findings oc- carred in gatifloxacin group and levefloxacin group were 24. 8% (30 /121) and 22. 1 % (27 /112) respectively. All were mild and transient, and there was no statistically significant difference between the two groups. Conclusions: Gatifloxacin given intravenously used as initial therapy in infectious patients with systemic clinical manifestations and followed by oral administration for the completion of therapy may get satisfactory results. The clinical efficacy of gatifloxacin is as good as that of levofloxacin. The adverse reaction rate of gatifloxacin was slightly higher than that of levofloxacin, but all the reactions are mild and tolerable.

目的:评价加替沙星注射液的疗效与安全性。方法:本研究为多中心、单盲、随机、对照试验,下呼吸道及尿路感染患者被随机分配接受加替沙星或左氧氟沙星静脉给药继以口服序贯治疗。结果:(1)试验组和对照组临床有效率分别为92.4%(110/119)和91.2%(114/125),其中下呼吸道感染两组有效率为94.2%(65/69)和90.2%(65/72),尿路感染两组有效率为90.0%(45/50)和92.5%(42/72),经统计学分析2组间差异无显著性;(2)两组总的细菌清除率分别为94.0%(78/83)和88.0%(81/92),其中尿路感染细菌清除率为89.2%(33/37)和92.9%(39/42),两组间差异无显著性;但试验组下呼吸道感染细菌清除率为97.8%(45/46),高于对照组的84.3%(43/51),差异有显著性;(3)试验组不良反应发生率为29.9%(38/127),显著高于对照组的10.1%(13/129);两组不良反应均系轻度,患者可耐受,无中途停药者。两组实验室检查异常者分别占24.8%(30/121)和22.1%(27/122),均系轻度并呈一过性,经统计学分析差异无显著性。结论:加...

目的:评价加替沙星注射液的疗效与安全性。方法:本研究为多中心、单盲、随机、对照试验,下呼吸道及尿路感染患者被随机分配接受加替沙星或左氧氟沙星静脉给药继以口服序贯治疗。结果:(1)试验组和对照组临床有效率分别为92.4%(110/119)和91.2%(114/125),其中下呼吸道感染两组有效率为94.2%(65/69)和90.2%(65/72),尿路感染两组有效率为90.0%(45/50)和92.5%(42/72),经统计学分析2组间差异无显著性;(2)两组总的细菌清除率分别为94.0%(78/83)和88.0%(81/92),其中尿路感染细菌清除率为89.2%(33/37)和92.9%(39/42),两组间差异无显著性;但试验组下呼吸道感染细菌清除率为97.8%(45/46),高于对照组的84.3%(43/51),差异有显著性;(3)试验组不良反应发生率为29.9%(38/127),显著高于对照组的10.1%(13/129);两组不良反应均系轻度,患者可耐受,无中途停药者。两组实验室检查异常者分别占24.8%(30/121)和22.1%(27/122),均系轻度并呈一过性,经统计学分析差异无显著性。结论:加替沙星注射剂静脉给药用于全身症状明显感染的初期治疗可使病情早期缓解,继以口服完成疗程,可获良好疗效;加替沙星组临床疗效与对照组相仿,虽不良反应多于对照组,但均属轻度并可为患者耐受。

Objective To evaluate the efficacy of meropenem in moderate to severe bacterial infection.Methods A randomized comparative study was conducted to compare the efficacy of meropenem and imipenern in the treatment of 158 cases of moderate to severe infection in ICU.Results 79 patients of moderate to severe infection were enrolled into meropenem group with an effective rate of 83.5%,on the other hand,79 patients were enrolled into imipenem group with an effective rate of 84.8%.Conclusion Meropenem can be employed...

Objective To evaluate the efficacy of meropenem in moderate to severe bacterial infection.Methods A randomized comparative study was conducted to compare the efficacy of meropenem and imipenern in the treatment of 158 cases of moderate to severe infection in ICU.Results 79 patients of moderate to severe infection were enrolled into meropenem group with an effective rate of 83.5%,on the other hand,79 patients were enrolled into imipenem group with an effective rate of 84.8%.Conclusion Meropenem can be employed for the treatment of moderate to severe bacterial infection.

目的观察美罗培南治疗中、重度细菌感染的有效性。方法采用随机对照、平行试验设计,对重症监护病房(ICU)158例中、重度细菌感染患者给予美罗培南治疗并观察临床疗效。结果美罗培南组79例,临床有效率为83.5%;亚胺培南组79例,临床有效率为84.8%。结论美罗培南治疗各种中、重度细菌感染的疗效与亚胺培南相似。

 
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关randomized comparative study的内容
在知识搜索中查有关randomized comparative study的内容
在数字搜索中查有关randomized comparative study的内容
在概念知识元中查有关randomized comparative study的内容
在学术趋势中查有关randomized comparative study的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社